ALB and coronary artery disorder: A previous study showed an inverse relationship between platelet activation and serum albumin <3.5 g/dL in patients affected by stable coronary artery disease but data regarding COX-1 inhibition as well as its impact with clinical outcomes was not investigated (Shiyovich et al., 2020).